← All candidates
16 insider filings on record.
20 filings on record.
TCRTAlaunos Therapeutics, Inc.
NasdaqCM · Healthcare · $4.50M
$1.79
+2.34% today
16 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what TCRT ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$4.50M
Float
2.0M
78% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
1499.0
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
11 more transactions on Pro →Context
Earnings · EPS vs forecast
3 of 4 quarters beat
Q4 '23−$17.09 act−$12.59
Q3 '23−$4.41 act+$0.84
Q2 '23−$6.00 act+$0.75
Q1 '23−$6.00 act+$0.60
The file stays open
20 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice